STOCK TITAN

Hoth Therapeutics Announces Pipeline Presentation at the 2022 Sidoti Investor Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced its presentation at the Sidoti Investor Conference on August 17-18, 2022. The company focuses on developing innovative biopharmaceutical treatments aimed at improving patient quality of life. Hoth is dedicated to early-stage pharmaceutical research and collaborates with scientists and clinicians to explore impactful therapeutics. For more details on the conference, interested parties can visit the Sidoti website.

Positive
  • Presentation at Sidoti Investor Conference could enhance investor visibility and interest.
  • Focus on innovative biopharmaceutical treatments aligns with patient needs.
Negative
  • None.

NEW YORK, Aug. 12, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced today announced the company will be presenting at the Sidoti Investor Conference taking place on August 17-18, 2022.

To learn more about the Sidoti Investor Conference or register to attend visit https://www.sidoti.com/events

About Hoth Therapeutics, Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate therapeutics that hold immense potential to create  breakthroughs  and  diversify  treatment  options.  To  learn  more,  please visit https://ir.hoththerapeutics.com/.

Investor Contact:
LR Advisors LLC
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-pipeline-presentation-at-the-2022-sidoti-investor-conference-301605156.html

SOURCE Hoth Therapeutics, Inc.

FAQ

What date will Hoth Therapeutics present at the Sidoti Investor Conference?

Hoth Therapeutics will present at the Sidoti Investor Conference on August 17-18, 2022.

What is the stock symbol for Hoth Therapeutics?

The stock symbol for Hoth Therapeutics is HOTH.

What is the focus of Hoth Therapeutics?

Hoth Therapeutics focuses on developing innovative biopharmaceutical treatments to improve patient quality of life.

Where can I find more information about the Sidoti Investor Conference?

More information about the Sidoti Investor Conference can be found on their official website.

Hoth Therapeutics, Inc.

NASDAQ:HOTH

HOTH Rankings

HOTH Latest News

HOTH Stock Data

5.31M
6.84M
0.93%
5.31%
5.34%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NEW YORK